Tag: Anticoagulants
Pulmonary Embolism Risk Elevated for More Than Six Weeks Postop
Findings based on six common surgery types in large French study
Study Compares Anticoagulants for Antiphospholipid Syndrome
Authors find rivaroxaban not noninferior to vitamin K antagonists for secondary thromboprophylaxis
Pharmacist in ED Cuts Time to Tx to Reverse Anticoagulation
Time to 4F-PCC shorter for patients who have life-threatening bleeding, need urgent procedures
Continuous Anticoagulants + Cold Snare Polypectomy Noninferior
Findings seen among patients with subcentimeter colorectal polyps receiving oral anticoagulants
Non-Vitamin K Oral Anticoagulants May Be Best for Early-Stage CKD
Benefit-risk profile superior to vitamin K antagonists for early-stage chronic kidney disease
History of Liver Disease Does Not Impact Efficacy of Edoxaban
Patients with a-fib and history of liver disease more often had major bleeding but no increase in SSEE
Vitamin K Can Up Anticoagulation Stability in Patients on Warfarin
Findings seen in warfarin-treated patients with history of international normalized ratio instability
Antiplatelets Do Not Up Recurrence in Intracerebral Hemorrhage
In population with cerebral microbleeds, no increased risk seen for those starting antiplatelet therapy
Dabigatran Does Not Beat Aspirin for Preventing Recurrent Stroke
Efficacy similar to aspirin for preventing recurrent stroke after embolic stroke of undetermined source
ASA: Reversal Agent Cuts Severe Bleeding With Factor Xa Inhibitors
Bolus plus two-hour infusion of andexanet alfa cuts antifactor Xa activity by 92 percent
